Glenn Stoller, MD
Ophthalmology · Rockville Centre, NYNPI 1558366526
Payments from drug & device makers
Across 339 payments — averaging $6100.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$1.5M
- Roche TCRC, Inc.$286K
- Apellis Pharmaceuticals, Inc.$195K
- Regeneron$27K
- Bayer$10K
- Novartis$7K
- plus $5K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 158 | $1,537,300 |
| Roche TCRC, Inc. | 21 | $286,299 |
| Apellis Pharmaceuticals, Inc. | 28 | $194,639 |
| Regeneron | 1 | $27,380 |
| Bayer | 2 | $10,341 |
| Novartis | 31 | $6,716 |
| Genentech USA, Inc. | 23 | $3,013 |
| AbbVie(2 entities) | 27 | $760 |
| Biotissue Holdings Inc. | 11 | $420 |
| Mallinckrodt Hospital Products Inc. | 8 | $254 |
| Harrow Eye, LLC | 3 | $168 |
| Aerie Pharmaceuticals, Inc. | 4 | $165 |
| Regeneron Healthcare Solutions, Inc. | 1 | $139 |
| AstraZeneca | 1 | $100 |
| Coherus Oncology, Inc. | 2 | $59 |
| Bausch & Lomb Americas Inc. | 3 | $57 |
| Amgen | 3 | $53 |
| Kala Pharmaceuticals, Inc. | 2 | $38 |
| Alcon | 2 | $34 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $34 |
| Sun Pharmaceutical Industries Inc. | 2 | $33 |
| Mallinckrodt Enterprises LLC | 1 | $26 |
| Tarsus Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
| Alimera Sciences, Inc. | 1 | $15 |
How this compares
$2,068,086 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Rockville Centre
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Philip FerroneGreat Neck$5.8M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Richard SpaideNew York$1.7M
- Paul HartmanRochester$1.6M
- Jason SlakterNew York$1.2M
- David ChuNew York$1.2M
- Jonathan JonischGreat Neck$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.